Catalyst Wire Dossier Catalyst Wire Dossier

IRBESARTAN AND HYDROCHLOROTHIAZIDE

irbesartan and hydrochlorothiazide · Hikma Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

47 regulatory and trial events tracked for IRBESARTAN AND HYDROCHLOROTHIAZIDE, covering 2012-03-30 to 2026-03-05. Get the full timeline:

Most recent: FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)

See pricing